High-dose therapy and ASCT versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: Long term results

被引：0
|
作者：
Carella, A. M. [1 ]
Bellei, M. [2 ]
Brice, P. [3 ]
Gisselbrecht, C. [3 ]
Visani, G. [4 ]
Colombat, P. [5 ]
Fabbiano, F. [6 ]
Donelli, A. [7 ]
Feugier, P. [8 ]
Browett, P. [9 ]
Hagberg, H. [10 ]
Federico, M. [2 ]
机构：
[1] Osped San Martino Genova, Div Ematol 1, Genoa, Italy
[2] Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy
[3] Hop St Louis, Inst Hematol, Paris, France
[4] Osped San Salvatore, Div Ematol, Pesaro, Italy
[5] Ctr Hop Bretonneau, Serv Oncol Med & Malad Sang, Tours, France
[6] Osped Cervello, Div Ematol, Palermo, Italy
[7] Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy
[8] Univ Hosp Nancy, Dept Hematol Internal Med, Nancy, France
[9] Univ Auckland, Mol Hematol & Lab Med, Auckland 1, New Zealand
[10] Uppsala Univ, Dept Radiol & Clin Immunol, S-75105 Uppsala, Sweden
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] Low-Dose Rituximab and High-Dose Dexamethasone As Front-Line Therapy in Adult Patients with Primary Immune Thrombocytopenia
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz C.
    Moreno-Jaime, Brizio
    Jaime-Perez, Jose C.
    Ceballos-Lopez, Adrian A.
    Ruiz-Argueelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar H.
    BLOOD, 2012, 120 (21)
  • [22] High-dose therapy and autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy. Analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol
    Federico, M
    Clo, V
    Carella, AM
    LEUKEMIA, 1996, 10 : S69 - S71
  • [23] Long-term event-free survival (EFS) after intensive therapy with etoposide, melphalan and autotransplant in patients failing front-line therapy for Hodgkin's disease and non-Hodgkin's lymphoma.
    Prince, HM
    Crump, M
    Imrie, K
    Stewart, AK
    Keating, A
    BLOOD, 1995, 86 (10) : 825 - 825
  • [24] Could cisplatin as a front-line treatment in childhood non-Hodgkin's lymphoma be a promising therapy?
    Papadopoulou, AL
    Moschovi, M
    Panagopoulou-Cristaki, M
    Anagnostou-Keramida, D
    Van Vliet-Constantinidou, C
    Botsonis, A
    Tsangaris, GT
    Tzortzatou-Stathopoulou, F
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1999, 16 (04) : 341 - 346
  • [25] Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
    Haige Ye
    Aakash Desai
    Shengjian Huang
    Dayoung Jung
    Richard Champlin
    Dongfeng Zeng
    Fangfang Yan
    Krystle Nomie
    Jorge Romaguera
    Makhdum Ahmed
    Michael L. Wang
    Journal of Experimental & Clinical Cancer Research, 37
  • [26] Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy
    Ye, Haige
    Desai, Aakash
    Huang, Shengjian
    Jung, Dayoung
    Champlin, Richard
    Zeng, Dongfeng
    Yan, Fangfang
    Nomie, Krystle
    Romaguera, Jorge
    Ahmed, Makhdum
    Wang, Michael L.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [27] Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma
    Yasenchak, Christopher A.
    Tseng, Wan-Yu
    Yap, Mark
    Rembert, Debra
    Patt, Debra A.
    LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3143 - 3149
  • [28] Aggressive non-Hodgkin's lymphoma - Economics of high-dose therapy
    Beard, SM
    Wall, L
    Gaffney, L
    Sampson, F
    PHARMACOECONOMICS, 2004, 22 (04) : 207 - 224
  • [29] Bone Loss in Lymphoma Patients Prior to Receiving Front-line Therapy
    Westin, Jason R.
    Thompson, Michael A.
    Cataldo, Vince D.
    Toth, Bela B.
    Sanjorjo, Perpetua
    Bourgeois, Scott
    Jimenez, Camilo
    Murphy, William A.
    Fanale, Michelle
    Fayad, Luis
    Fowler, Nathan
    Kwak, Larry
    McLaughlin, Peter
    Neelapu, Sattva
    Pro, Barbara
    Rodriguez, Alma
    Shah, Jatin
    Hagemeister, Fredrick B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (03): : E32 - E32
  • [30] Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
    Yuen, AR
    Rosenberg, SA
    Hoppe, RT
    Halpern, JD
    Horning, SJ
    BLOOD, 1997, 89 (03) : 814 - 822
12345